MDL Over Pfizer's Neurontin Soon To Be 46 Cases Lighter

Law360, New York (July 26, 2010, 4:25 PM EDT) -- Lawyers for hundreds of Neurontin multidistrict litigation plaintiffs, who accuse Pfizer Inc. of a fraudulent scheme to promote the anti-epilepsy drug for off-label use, have agreed to cut 46 cases from the proceedings, while missing a key deadline to proceed on behalf of more clients.

The Boone Law Firm PA said in a stipulation lodged Friday in the U.S. District Court for the District of Massachusetts that 33 of its clients had dismissed their claims, and it added in a separate filing that it had not...
To view the full article, register now.